Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New under-the-skin LARC launched

  • Comment

The first subcutaneously delivered long-acting reversible contraceptive (LARC) has been launched in the UK.

Medroxyprogesterone acetate (Sayana Press) is administered under the skin into the thigh or abdomen every 13 weeks using a prefilled Uniject injection.

The active ingredient, medroxyprogesterone acetate, is similar to the natural hormone progesterone produced in the ovaries.

The new Uniject device makes it “convenient and straightforward” for a doctor or nurse to administer, according to its manufacturer Pfizer.


Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.